Develops novel treatments for infectious diseases, including HIV and Hepatitis C.
Industry: Health Care
First Day Return: +7.7%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 03/31/2006 |
Offer Price | $11.50 |
Price Range $14.00 - $16.00 | |
Offer Shares (mm) | 4.5 |
Deal Size ($mm) | $52 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 10/25/2006 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $52 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | New Haven, CT, United States |
Founded | 1998 |
Employees at IPO | 65 |
Website www.achillion.com |